Hyaluronan influence on diffusive permeability of the peritoneum in vitro.

Adv Perit Dial

Department of Chemistry and Clinical Biochemistry, Poznań University of Medical Sciences, Poznań, Poland.

Published: December 2008

Hyaluronan (HA), an essential component of peritoneal extracellular matrix, participates in restoring peritoneal integrity and remodeling the peritoneum changed by prolonged peritoneal dialysis and repeated peritonitis episodes. The aim of the present study was to compare urea, creatinine, and uric acid transport across the peritoneal membrane in control conditions and after HA application. Experiments were undertaken using rabbit parietal peritoneum and a modified Ussing-type chamber. Values of the transfer directed from the interstitial to the mesothelial side of the membrane (I --> M) and in the opposite direction (M --> I) were expressed as coefficients of diffusive permeability P. Transperitoneal transport in control conditions (for 120 minutes) and transfer parameters before (15 - 60 minutes) and after HA application (2000 kDa, 0.04 g/dL, 75-120 minutes) were examined. In the control series, stability of bidirectional transport for urea (0.02 g/dL), creatinine (0.1 g/dL), and uric acid (0.02 g/dL) was observed. The values of P +/- standard error of the mean for I --> M and M --> I transfers were respectively 2.293 +/- 0.211 and 2.621 +/- 0.457 for urea, 1.522 +/- 0.102 and 1.865 +/- 0.244 for creatinine, and 1.936 +/- 0.324 and 2.078 +/- 0.186 for uric acid [all x 10(-4) cm/s]. Application of HA reduced bi-directional urea transport by a mean of 12%, but did not change the P for creatinine and uric acid. These results show that in vitro HA modifies the dynamics of transport for certain small solutes.

Download full-text PDF

Source

Publication Analysis

Top Keywords

uric acid
16
diffusive permeability
8
creatinine uric
8
control conditions
8
002 g/dl
8
+/-
7
transport
5
hyaluronan influence
4
influence diffusive
4
permeability peritoneum
4

Similar Publications

Targeting uric acid: a promising intervention against oxidative stress and neuroinflammation in neurodegenerative diseases.

Cell Commun Signal

January 2025

Department of Anesthesiology, Cheeloo College of Medicine, Qilu Hospital (Qingdao), Shandong University, 758 Hefei Road, Qingdao, China.

Oxidative stress and neuroinflammation are recognized as key factors in the development of neurodegenerative diseases, yet effective interventions and biomarkers to address oxidative stress and neuroinflammation in these conditions are limited. Uric acid (UA), traditionally associated with gout, is now gaining prominence as a potential target in neurodegenerative diseases. Soluble UA stands out as one of the most vital antioxidant compounds produced by the human body, accounting for up to 55% of the extracellular capacity to neutralize free radicals.

View Article and Find Full Text PDF

Association between obstructive sleep apnea and hyperuricemia/gout in the general population: a cross-sectional study.

BMC Musculoskelet Disord

January 2025

Department of Internal Medicine, Division of Rheumatology, Soonchunhyang University Seoul Hospital, Soonchunhyang University School of Medicine, Seoul, South Korea.

Background: Obstructive sleep apnea (OSA) is linked to various health conditions, including cardiovascular diseases and metabolic disorders. Hyperuricemia and gout may be associated with OSA, but large-scale studies on this are limited. This study aimed to investigate the association between hyperuricemia/gout and OSA using data from the Korea National Health and Nutrition Survey (KNHANES).

View Article and Find Full Text PDF

Background: Primary hypertension (PH) poses significant risks to children and adolescents. Few prediction models for the risk of PH in children and adolescents currently exist, posing a challenge for doctors in making informed clinical decisions.

Objective: This study aimed to investigate the incidence and risk factors of PH in Chinese children and adolescents.

View Article and Find Full Text PDF

Discovery of cyanidin-3-O-galactoside as a novel CNT2 inhibitor for the treatment of hyperuricemia.

Bioorg Chem

December 2024

Good Clinical Practice Development, Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China. Electronic address:

Inhibition of human concentrative nucleoside transporter 2 (CNT2) could suppress increases in serum urate levels derived from dietary purines. However, the structural basis for substrate recognition of CNT2 is still unknown and only a few inhibitors have been reported. In this study, a homology model of CNT2 was constructed and residues T315, E316, N426, N491, E492, F536 and N538 were identified as binding sites for adenosine through site-directed mutagenesis and a H-adenosine uptake assay.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!